MR-HIFU and ThermoDox to Treat Recurrent Childhood Tumors: Interview with AeRang Kim, Principal Investigator
Children’s National Health System and the Celsion Corporation (Lawrenceville, NJ) have recently announced a Phase I clinical trial in the US to determine a safe and tolerable dose of ThermoDox in conjunction with non-invasive magnetic resonance-gu...
Source: Medgadget - Category: Medical Equipment Authors: Conn Hastings Tags: Exclusive Nanomedicine Oncology Source Type: blogs
More News: Bone Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Cancer in Young Adults | Chemotherapy | Childhood Cancer | Children | Clinical Trials | Ewing's Sarcoma | Germ Cell Tumors | High Intensity Focused Ultrasound Therapy | Hospitals | Legislation | Liver | Nanotechnology | Neuroblastoma | Neurology | Osteosarcoma | Pediatrics | Rhabdomyosarcoma | Sarcomas | Study | Technology Consultants | Ultrasound | Urology & Nephrology | Wilm's Tumor